UBE3A antibody

Synonyms:ANCR antibody, AS antibody, E6 AP antibody, E6AP antibody, E6AP ubiquitin protein ligase antibody, EPVE6AP antibody, FLJ26981 antibody, HPVE6A antibody, UBE3A antibody, ubiquitin protein ligase E3A antibody
Catalogue No.:FNab09189Reactivity:Human, Mouse, Rat
Host:RabbitTested Application:ELISA, WB, IHC
Clonality:polyclonalIsotype:IgG
  • SPECIFICATIONS
Product Name
UBE3A antibody
Catalogue No.
FNab09189
Size
100μg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months (Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
ubiquitin protein ligase E3A
Alternative Names
ANCR antibody, AS antibody, E6 AP antibody, E6AP antibody, E6AP ubiquitin protein ligase antibody, EPVE6AP antibody, FLJ26981 antibody, HPVE6A antibody, UBE3A antibody, ubiquitin protein ligase E3A antibody
UniProt ID
Q05086
Observed MW
110 kDa
Application
Tested Applications
ELISA, WB, IHC
Recommended dilution
WB: 1:500 - 1:2000; IHC: 1:50 - 1:200
Validated Images
mouse brain tissue were subjected to SDS PAGE followed by western blot with FNab09189(UBE3A antibody) at dilution of 1:1000
Immunohistochemistry of paraffin-embedded human kidney using FNab09189(UBE3A antibody) at dilution of 1:100
Background
This gene encodes an E3 ubiquitin-protein ligase, part of the ubiquitin protein degradation system. This imprinted gene is maternally expressed in brain and biallelically expressed in other tissues. Maternally inherited deletion of this gene causes Angelman Syndrome, characterized by severe motor and intellectual retardation, ataxia, hypotonia, epilepsy, absence of speech, and characteristic facies. The protein also interacts with the E6 protein of human papillomavirus types 16 and 18, resulting in ubiquitination and proteolysis of tumor protein p53. Alternative splicing of this gene results in three transcript variants encoding three isoforms with different N-termini. Additional transcript variants have been described, but their full length nature has not been determined.